methadone has been researched along with Kidney Diseases in 8 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Examples of situations that characterise these special populations are: co-infection with hepatitis virus B and/or C, pregnancy, lipodystrophy, cardiovascular risk, renal failure, treatment of children and adolescents, immigrant health care, and the management of patients receiving methadone replacement therapy, among others." | 4.84 | [Utility of atazanavir in special populations]. ( Antela López, A, 2008) |
| "Methadone hydrochloride is a mu-opioid agonist that has been used for the treatment of pain and for the management and maintenance of opioid withdrawal for over 50 years." | 4.81 | Clinical use of methadone. ( Goode, JV; Layson-Wolf, C; Small, RE, 2002) |
| " Data collected included demographic data, laboratory tests, antiretroviral treatment history, methadone dosing and drug abstinence." | 1.51 | Risk factors for kidney disease among HIV-1 positive persons in the methadone program. ( Firląg-Burkacka, E; Grycner, E; Horban, A; Kowalska, JD; Matłosz, B; Pietraszkiewicz, E, 2019) |
| "In this study we describe a renal lipidosis occurring in patients with a positive history of narcotic abuse who were enrolled in a methadone substitution program." | 1.40 | Renal lipidosis in patients enrolled in a methadone substitution program. ( Birk, HW; Floege, J; Gröne, HJ; Kuppe, C; Maier, T; Moeller, MJ; Porubsky, S; Wörnle, M, 2014) |
| "Parenteral substance abuse is widespread." | 1.27 | Primary care of parenteral substance abusers. ( Williams, A, 1986) |
| "Hypertension was present in 2." | 1.25 | Prevalence of renal disease in asymptomatic heroin addicts. ( Arruda, JA; Kurtzman, NA; Pillay, VK, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matłosz, B | 1 |
| Pietraszkiewicz, E | 1 |
| Firląg-Burkacka, E | 1 |
| Grycner, E | 1 |
| Horban, A | 1 |
| Kowalska, JD | 1 |
| Porubsky, S | 1 |
| Kuppe, C | 1 |
| Maier, T | 1 |
| Birk, HW | 1 |
| Wörnle, M | 1 |
| Moeller, MJ | 1 |
| Floege, J | 1 |
| Gröne, HJ | 1 |
| Antela López, A | 1 |
| Layson-Wolf, C | 1 |
| Goode, JV | 1 |
| Small, RE | 1 |
| Arruda, JA | 1 |
| Kurtzman, NA | 1 |
| Pillay, VK | 1 |
| Rosenkranz, RP | 1 |
| Henderson, GL | 1 |
| Wood, M | 1 |
| Williams, A | 1 |
3 reviews available for methadone and Kidney Diseases
| Article | Year |
|---|---|
[Utility of atazanavir in special populations].
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cardi | 2008 |
Clinical use of methadone.
Topics: Analgesics, Opioid; Biological Availability; Dosage Forms; Drug Administration Schedule; Drug Intera | 2002 |
Plasma drug binding: implications for anesthesiologists.
Topics: Age Factors; Alfentanil; Alprenolol; Anesthesia; Anesthetics; Blood Proteins; Bupivacaine; Burns; Ca | 1986 |
5 other studies available for methadone and Kidney Diseases
| Article | Year |
|---|---|
Risk factors for kidney disease among HIV-1 positive persons in the methadone program.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Drug Therapy, Combination; Female; Glomerular Filtration | 2019 |
Renal lipidosis in patients enrolled in a methadone substitution program.
Topics: Adult; Biopsy; Disease Progression; Female; Humans; Kidney; Kidney Diseases; Lipid Metabolism; Lipid | 2014 |
Prevalence of renal disease in asymptomatic heroin addicts.
Topics: Chicago; Creatine; Evaluation Studies as Topic; Heroin Dependence; Humans; Hypertension; Inactivatio | 1975 |
Renal toxicity of l-alpha-acetylmethadol (LAAM) in the rat.
Topics: Animals; Hematuria; Kidney Diseases; Kidney Tubules; Methadone; Methadyl Acetate; Morphine; Naloxone | 1975 |
Primary care of parenteral substance abusers.
Topics: Acquired Immunodeficiency Syndrome; Administration, Intranasal; Antibodies, Viral; Body Weight; Coca | 1986 |